07.01.2005 15:03:00

Biomet, Inc. to Hold Analyst Meeting During the American Academy of Or

Biomet, Inc. to Hold Analyst Meeting During the American Academy of Orthopaedic Surgeons


    Business Editors/Health/Medical Writers

    WARSAW, Ind.--(BUSINESS WIRE)--Jan. 7, 2005--Biomet, Inc. (NASDAQ:BMET) will hold an Analyst Meeting on Wednesday, February 23, during the 2005 American Academy of Orthopaedic Surgeons Annual Meeting. The meeting will be held in the Vista Ballroom at the Wyndham Washington, D.C., 1400 M Street NW.
    Registration and reception will begin at 6:00 p.m. with meeting to follow at 6:30 p.m., Eastern Time. President and Chief Executive Officer Dane A. Miller, Ph.D. will be presenting. Guest speakers will be orthopedic surgeons Professor David W. Murray, M.D., F.R.C.S. and Keith R. Berend, M.D.
    A simultaneous live webcast of the meeting will be accessible through the Company's website at www.biomet.com (Investor Section) or at www.streetevents.com.
    Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. The Company's product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 100 countries.

--30--JAM/cl*

CONTACT: Biomet, Inc. Carolyn Beatty, Investor Relations, 574-372-1571 Barbara Goslee, Corporate Communications, 574-372-1514

KEYWORD: INDIANA INDUSTRY KEYWORD: MEDICAL DEVICES MEDICAL BIOTECHNOLOGY SOURCE: Biomet, Inc.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Biomet Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Biomet Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 627,44 -0,28%
S&P 500 6 040,53 -0,50%
NASDAQ 100 21 478,05 -0,14%